- | Page
NURS 615 PHARM EXAM 1 –
MARYVILLE LATEST (100%
CORRECT ANSWER S)
Question : How does hypoalbuminemia affect the process
of prescribing?
CORRECT ANSWER : Low albumin = more free drug
(bc the drug can't bind to albumin aka protein) = increased adverse effects
Question : What is a Black Box Warning:
CORRECT ANSWER : is considered a contraindication
to administer that drug.
Question : What is the drugs half-life?
CORRECT ANSWER : Half-life specifically means the
amount of time it takes for an administered drug to be halfway cleared from the system.
- | Page
Question : Peak of action:
CORRECT ANSWER : the time between drug
administration and maximum concentration of drug in the blood stream. Best therapeutic effect.
Question : Duration of action:
CORRECT ANSWER : the time between onset of action
and metabolism of drug below the minimum needed for an effect. The length of time you have the drug in your system.
Question : According to the WHO what is the first step in
the prescribing process?
CORRECT ANSWER : The first step is to define the
patient's problem
Question : The second step is to
CORRECT ANSWER : specify the therapeutic objective
- | Page
Question : The third step is to
CORRECT ANSWER : choose which drug or treatment
is needed.
Question : Step 4 of the WHO approach:
CORRECT ANSWER : Start the treatment
Question : Step 5 of the WHO approach:
CORRECT ANSWER : Educate the patient
Question : Step 6 of the WHO approach:
CORRECT ANSWER : Monitor the treatment
Question : Phase 1 of drug development:
CORRECT ANSWER : The drug is tested on healthy
volunteers
- | Page
Question : Phase 2 of drug development:
CORRECT ANSWER : trials with people who have the
disease for which the drug is thought to be effective
Question : Phase 3 of drug development:
CORRECT ANSWER : Large numbers of patients in
medical research centers receive the drug in phase 3. This larger sampling provides information about infrequent or rare adverse effects. The FFA will approve a new drug application if phase 3 studies are satisfactory.
Question : Phase 4 of drug development:
CORRECT ANSWER : This phase is voluntary and
involves postmarket surveillance of the drug's therapeutic effects at the completion of phase 3. The pharmaceutical company receives reports from doctors and other health care professionals about the therapeutic results and adverse effects of the drug. Some medications, for